Finance

Beta
Lists
ALLR:NASDAQ
Allarity Therapeutics Inc
$1.61
-5.29%
(-0.090) 1D
Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALLR...
Open
$1.71
High
$1.72
Low
$1.56
Mkt. cap
25.62M
Avg. vol.
243.45K
Volume
157.00K
52-wk high
$2.35
52-wk low
$0.77
EPS
-$0.72
Beta
0.23
Shares outstanding
15.91M
No. of employees
7
Open
$1.71
High
$1.72
Low
$1.56
Mkt. cap
25.62M
Avg. vol.
243.45K
Volume
157.00K
52-wk high
$2.35
52-wk low
$0.77
EPS
-$0.72
Beta
0.23
Shares outstanding
15.91M
No. of employees
7
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to ALLR in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for ALLR in the last 3 months.
Highest
Current $1.61
$9.75 (+505.59%)
Average
$9.75 (+505.59%)
Lowest
$9.75 (+505.59%)
News stories
From sources across the web
About Allarity Therapeutics Inc
CEO-
Employees7
Founded-
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websiteallarity.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
320.00K
25.00K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.32M
1.20M
2.51M
1.30M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.81M
1.32M
1.56M
1.42M
Operating expense
4.13M
2.52M
3.24M
2.71M
Total operating expenses
4.13M
2.52M
3.24M
2.71M
Operating income
-4.13M
-2.52M
-2.92M
-2.69M
Other non operating income
-
-
-
-
EBT including unusual items
-2.32M
-2.81M
-3.37M
-2.75M
EBT excluding unusual items
-2.32M
-2.81M
-3.37M
-2.75M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-833.00K
-
Net income
-2.32M
-2.81M
-3.37M
-2.75M
Net profit margin
-
-
-1,054.06%
-11,000.00%
Earnings per share
-0.15
-0.19
-0.21
-0.17
Interest and investment income
237.00K
187.00K
155.00K
163.00K
Interest expense
-12.00K
-57.00K
-59.00K
-229.00K
Net interest expenses
225.00K
130.00K
96.00K
-66.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.12M
-2.51M
-2.91M
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer